Urolithin A supplement company Timeline has investments from both Nestlé and L'Oréal.
This year, the conversation quickly turned to the supplement du jour, the compound that has drawn investment from both Nestlé and L'Oréal: Urolithin A.
Starting in 2008, Rinch's supplement company, Amazentis, funded over a dozen studies on urolithin A, including some relatively large, placebo-controlled trials in people — a rarity in supplement research.
Urolithin A has also captured the attention of longevity researchers, who are typically more skeptical about products promising to make you young again.
Timeline was on the agenda at this year's ARDD, an annual longevity research conference held in Copenhagen in August.
Persons:
—, There's, Urolithin, Hilary Brueck, Chris Rinsch, Rinsch, Johan Auwerx, Amazentis, Auwerx, He's, Mark Hyman, Dave Asprey, Gwyneth Paltrow's, Will Cole, Dominic Denk, Denk, wouldn't, Timeline's, Andrea Maier, it's, Maier
Organizations:
Service, VC, Business, Frankfurt University Hospital, National University of Singapore
Locations:
Gstaad, Swiss, skincare, urolithin, Davos, Copenhagen, Germany, Switzerland, Nestlé